Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
Abstract Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-12-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.3302 |
| _version_ | 1818904696526471168 |
|---|---|
| author | Hninyee Win Krisstina Gowin |
| author_facet | Hninyee Win Krisstina Gowin |
| author_sort | Hninyee Win |
| collection | DOAJ |
| description | Abstract Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease. |
| first_indexed | 2024-12-19T21:11:33Z |
| format | Article |
| id | doaj.art-6734df26ec944433a2128cad41e2e9fc |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-12-19T21:11:33Z |
| publishDate | 2020-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-6734df26ec944433a2128cad41e2e9fc2022-12-21T20:05:28ZengWileyClinical Case Reports2050-09042020-12-018123042304810.1002/ccr3.3302Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literatureHninyee Win0Krisstina Gowin1Department of Medicine University of Arizona Tucson ArizonaDepartment of Hematology and Oncology University of Arizona Tucson ArizonaAbstract Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.https://doi.org/10.1002/ccr3.3302bortezomiblenalidomideparaproteinemiaplasma cellsscleromyxedematreatment |
| spellingShingle | Hninyee Win Krisstina Gowin Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature Clinical Case Reports bortezomib lenalidomide paraproteinemia plasma cells scleromyxedema treatment |
| title | Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature |
| title_full | Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature |
| title_fullStr | Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature |
| title_full_unstemmed | Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature |
| title_short | Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature |
| title_sort | treatment of scleromyxedema with lenalidomide bortezomib and dexamethasone a case report and review of the literature |
| topic | bortezomib lenalidomide paraproteinemia plasma cells scleromyxedema treatment |
| url | https://doi.org/10.1002/ccr3.3302 |
| work_keys_str_mv | AT hninyeewin treatmentofscleromyxedemawithlenalidomidebortezomibanddexamethasoneacasereportandreviewoftheliterature AT krisstinagowin treatmentofscleromyxedemawithlenalidomidebortezomibanddexamethasoneacasereportandreviewoftheliterature |